Print Page

Tarceva® erlotinib tablets
polaroid 1
My passion is working in my garden...right there on my hands and knees, seeing things grow. - Tarceva patient

Financial Resources — We're Here to Help

Genentech® Access to Care Foundation

The Genentech® Access to Care Foundation was established to help patients with unmet medical needs who are uninsured or rendered uninsured by payer denial and who meet specific financial and medical criteria to receive proper medical treatment.

Tarceva Access Solutions

Handling insurance matters can be confusing. That is where Tarceva Access Solutions can help. Access Solutions is a free resource that can provide patients and healthcare providers (HCPs) with:

  • Coverage and reimbursement information
  • Patient assistance
  • Information about Tarceva

When seeking coverage and reimbursement help from Tarceva Access Solutions, there are 2 forms you and your doctor will need to complete:

  1. Statement of Medical Necessity (SMN) — a form filled out by your doctor.
  2. Patient Authorization and Notice of Release of Information (PAN) — a form you must sign and date. This form lets us discuss your case with you, your doctor, and your healthcare plan. It is easy to understand and has clear instructions on where to sign and date the form.

For more information, go to the Tarceva Access Solutions website, or talk with an
Access Solutions Specialist at 1 (888) 249-4918, 9AM-8PM EST, Monday through Friday.

Genentech BioOncology Co-pay Card Program*

Tarceva Access Solutions offers co-pay card support to help you with the out-of-pocket (OOP) costs of your Tarceva prescription.

Learn more about the program and to check to see if you qualify.

*Certain restrictions apply.
Out-of-pocket costs are defined as co-pay, co-insurance, or deductible.

Other financial resources

Genentech and Astellas are not affiliated with and do not endorse any of the listed organizations. The information provided by Genentech and Astellas is for informational purposes only and is not meant to replace your HCP's advice.

CancerCare

1 (800) 813-HOPE (1-800-813-4673)
Provides free counseling, education, information, referrals, and direct financial assistance to people with cancer.

NeedyMeds

Provides free information about patient assistance programs to help those who can't afford their medicines. NeedyMeds is not a program. It is simply a source of information.

Patient Advocate Foundation

1 (800) 532-5274
National organization that serves as an active partner to help patients and their insurance companies, employers, and/or creditors to solve problems related to patients' diagnoses.

What does Tarceva treat?

Tarceva is approved for:
Advanced Pancreatic Cancer:
  • Tarceva in combination with gemcitabine is prescribed for patients with advanced-stage pancreatic cancer whose cancer has spread, grown, or cannot be surgically removed and who have not received previous chemotherapy.
Important Safety Information

Possible Side Effects

Everyone reacts differently to Tarceva therapy. So it’s important to know what the side effects are. Although some people may have a life-threatening side effect, most do not.

Your doctor will stop treatment if any serious side effects occur. Be sure to contact your healthcare team if you have symptoms related to these side effects.

  • Interstitial lung disease (ILD)-like events
    Problems occurring in the lungs (including deaths). Tarceva may need to be stopped if new or unexplained serious symptoms of shortness of breath, cough, and fever occur.

  • Liver and/or kidney problems
    Some events have included death. Let your healthcare provider (HCP) know if you have a history of liver or kidney disease.

  • Gastrointestinal (GI) perforation
    A hole that develops in your stomach or intestine. Some events have included death.

  • Serious skin conditions
    Some events have included death.

  • Bleeding and clotting problems
    Heart attack or stroke in patients receiving Tarceva plus gemcitabine for advanced pancreatic cancer.

  • Eye disorders
    Eye irritation and damage to the cornea.

  • Bleeding events when taking warfarin
    Some events have included death. Tell your doctor if you are taking warfarin or non-steroidal anti-inflammatory drugs (NSAIDs).

  • Pregnancy problems
    You should not become pregnant while on treatment with Tarceva. DO NOT breast-feed while receiving treatment with Tarceva.

Additional Safety Information

Call your HCP right away if you have these signs or symptoms:

  • New or worsening skin rash
  • Serious or ongoing diarrhea, nausea, loss of appetite, or vomiting
  • New or worsening shortness of breath or cough
  • Eye irritation

The most common side effects are fatigue (feeling tired), rash, nausea, loss of appetite, and diarrhea.

Additional Important Information

It is important that you tell your HCP about all of the medicines and herbal supplements you are taking.

  • DO NOT start taking any new medicines or herbal supplements before talking with your HCP.
  • DO NOT eat grapefruit or drink grapefruit juice while on treatment with Tarceva, except under the care of your HCP.

Smoking may affect how well Tarceva works for you.

  • If you smoke, you should stop smoking before starting treatment with Tarceva.
  • If you continue to smoke, you should talk to your HCP before taking Tarceva.

Always let your HCP know if you have any side effects, and ask about the best way to handle them.

Tarceva is not right for everyone. Ask your HCP if once-daily Tarceva is right for you.

You may report side effects to the FDA at 1 (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1 (888) 835-2555.


Genentech Biooncology Astellas Oncology

More Information


Tarceva® erlotinib tablets